invivo.de valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# This space intentionally left blank # If you want to learn about why our robots.txt looks like this, read this post: https://yoa.st/robots-txt | ||
Meta Tags
| Title | InVivo – Excellence in custom |
| Description | Europe’s largest non-GMP contract manufacturer for cost-effective outsourcing solutions (with over 20 years of |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 213.133.116.74 |
| Location | Germany |
Related Websites
| Site | Rank |
More to Explore
invivo.de Valuation
|
US$302,794
Last updated: 2022-07-01 15:31:45
invivo.de has Semrush global rank of 34,955,485. invivo.de has an estimated worth of US$ 302,794, based on its estimated Ads revenue. invivo.de receives approximately 34,938 unique visitors each day. Its web server is located in Germany, with IP address 213.133.116.74. According to SiteAdvisor, invivo.de is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$302,794 |
| Daily Ads Revenue | US$280 |
| Monthly Ads Revenue | US$8,386 |
| Yearly Ads Revenue | US$100,621 |
| Daily Unique Visitors | 2,330 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| invivo.de. | A | 86399 | IP: 213.133.116.74 |
| invivo.de. | NS | 86400 | NS Record: robotns3.second-ns.com. |
| invivo.de. | NS | 86400 | NS Record: robotns2.second-ns.de. |
| invivo.de. | NS | 86400 | NS Record: ns1.first-ns.de. |
| invivo.de. | MX | 86400 | MX Record: 10 mail.invivo.de. |
| invivo.de. | TXT | 86400 | TXT Record: Sendinblue-code:d22deeca564a4f8a7685292eac216d11 |
| invivo.de. | TXT | 86400 | TXT Record: v=spf1 +mx +a:invivo.de include:spf.mailjet.com include:spf.sendinblue.com -all |
HtmlToTextCheckTime:2022-07-01 15:31:45
| Contact ISO Certificates Imprint Privacy Notice FAQ Download Center Recombinant Protein Production Antibody Production Monoclonal Antibody Production Recombinant Antibody Production Cell Line Development SARS-CoV-2 Antibodies and Antigens Additional Services About Us Team News Careers Select Page InVivo BioTech Excellence in custom bioproduction SARS-CoV-2 Antibodies and Antigens InVivo now offers recombinant antigens for Corona virus / COVID-19 in vitro diagnostics. Read more Europe’s largest non-GMP contract manufacturer InVivo is your partner for cost-effective outsourcing solutions with over 20 years of experience. Our capabilities and expertise allow us to work on highly specific questions and to deliver promptly with consistent high quality. All our employees are dedicated to developing premium quality solutions for research, diagnostic and preclinical use. As your full-service partner we accompany all project stages from antigen production to delivery of the final immunoassay |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: nginx Date: Wed, 27 Oct 2021 13:27:55 GMT Content-Type: text/html; charset=UTF-8 Connection: keep-alive Vary: Accept-Encoding,Cookie Expect-CT: max-age=2592000; Feature-Policy: autoplay none; camera none; document-domain self; encrypted-media self; fullscreen *; geolocation *; microphone none; midi none; payment none; vr none; X-Frame-Options: SAMEORIGIN Referrer-Policy: same-origin X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff Expires: Wed, 27 Oct 2021 14:27:55 GMT Cache-Control: max-age=3600 X-Redirect-By: WordPress Location: https://www.invivo.de/ Strict-Transport-Security: max-age=2592000; includeSubDomains; Expect-CT: max-age=2592000; Feature-Policy: autoplay none; camera none; document-domain self; encrypted-media self; fullscreen *; geolocation *; microphone none; midi none; payment none; vr none; Permissions-Policy: autoplay none; camera none; document-domain self; encrypted-media self; fullscreen *; geolocation *; microphone none; midi none; payment none; vr none; X-Frame-Options: SAMEORIGIN Referrer-Policy: same-origin X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff Content-Security-Policy: default-src 'self'; script-src 'self' 'unsafe-inline' 'unsafe-eval' *.google-analytics.com *.googleapis.com *.gstatic.com *.googleapis.com; style-src 'self' 'unsafe-inline'; img-src *; font-src 'self' data: *.gstatic.com X-Powered-By: PleskLin HTTP/2 200 server: nginx date: Wed, 27 Oct 2021 13:27:56 GMT content-type: text/html; charset=UTF-8 x-powered-by: PHP/7.3.28 vary: Accept-Encoding,Cookie cache-control: max-age=3, must-revalidate strict-transport-security: max-age=2592000; includeSubDomains; expect-ct: max-age=2592000; feature-policy: autoplay none; camera none; document-domain self; encrypted-media self; fullscreen *; geolocation *; microphone none; midi none; payment none; vr none; permissions-policy: autoplay none; camera none; document-domain self; encrypted-media self; fullscreen *; geolocation *; microphone none; midi none; payment none; vr none; x-frame-options: SAMEORIGIN referrer-policy: same-origin x-xss-protection: 1; mode=block x-content-type-options: nosniff content-security-policy: default-src 'self'; script-src 'self' 'unsafe-inline' 'unsafe-eval' *.google-analytics.com *.googleapis.com *.gstatic.com *.googleapis.com; style-src 'self' 'unsafe-inline'; img-src *; font-src 'self' data: *.gstatic.com x-powered-by: PleskLin |